High Mid-Flow to Vital Capacity Ratio and the Response to Exercise in Children With Congenital Heart Disease

References

1. 1.↵
   1. Green M,
   2. Mead J,
   3. Turner JM

   . Variability of maximum expiratory flow-volume curves. J Appl Physiol 1974;37(1):67–74.

   OpenUrlFREE Full Text
2. 2.↵
   1. Mead J

   . Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis 1980;121(2):339–342.

   OpenUrlPubMedWeb of Science
3. 3.↵
   1. Mirsadraee M,
   2. Boskabady MH,
   3. Attaran D

   . Diagnosis of chronic obstructive pulmonary disease earlier that current Global Initiative for Obstructive Lung Disease guidelines using a feasible spirometry parameter (maximal mid-expiratory flow/forced vital capacity). Chron Respir Dis 2013;10(4):191–196.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Tager IB,
   2. Weiss ST,
   3. Muñoz A,
   4. Welty C,
   5. Speizer FE

   . Determinants of response to eucapneic hyperventilation with cold air in a population-based study. Am Rev Respir Dis 1986;134(3):502–508.

   OpenUrlPubMedWeb of Science
5. 5.↵
   1. Parker AL,
   2. Abu-Hijleh M,
   3. McCool FD

   . Ratio between forced expiratory flow between 25% and 75% of vital capacity and FVC is a determinant of airway reactivity and sensitivity to methacholine. Chest 2003;124(1):63–69.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.
   1. Sheel AW,
   2. Guenette JA,
   3. Yuan R,
   4. Holy L,
   5. Mayo JR,
   6. McWilliams AM,
   7. et al

   . Evidence for dysanapsis using computed tomographic imaging of the airways in older ex-smokers. J Appl Physiol 2009;107(5):1622–1628.

   OpenUrlAbstract/FREE Full Text
7. 7.
   1. Litonjua AA,
   2. Sparrow D,
   3. Weiss ST

   . The FEF25-75/FVC ratio is associated with methacholine airway responsiveness. Am J Respir Crit Care Med 1999;159(5 Pt 1):1574–1579.

   OpenUrlPubMedWeb of Science
8. 8.↵
   1. Munakata M,
   2. Ohe M,
   3. Homma Y,
   4. Kawakami Y

   . Pulmonary dysanapsis, methacholine airway responsiveness and sensitization to airborne antigen. Respirology 1997;2(2):113–118.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Vilozni D,
   2. Lavie M,
   3. Sarouk I,
   4. Efrati O

   . Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation? Am J Respir Crit Care Med 2012;186(1):82–87.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Alonso-Gonzalez R,
    2. Borgia F,
    3. Diller GP,
    4. Inuzuka R,
    5. Kempny A,
    6. Martinez-Naharro A,
    7. et al

    . Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy, and association with survival. Circulation 2013;127(8):882–890.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Ginde S,
    2. Bartz PJ,
    3. Hill GD,
    4. Danduran MJ,
    5. Biller J,
    6. Sowinski J,
    7. et al

    . Restrictive lung disease is an independent predictor of exercise intolerance in the adult with congenital heart disease. Congenit Heart Dis 2013;8(3):246–254.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.
    1. Pianosi PT,
    2. Johnson JN,
    3. Turchetta A,
    4. Johnson BD

    . Pulmonary function and ventilatory limitation to exercise in congenital heart disease. Congenit Heart Dis 2009;4(1):2–11.

    OpenUrlCrossRefPubMed
13. 13.
    1. Hawkins SM,
    2. Taylor AL,
    3. Sillau SH,
    4. Mitchell MB,
    5. Rausch CM

    . Restrictive lung function in pediatric patients with structural congenital heart disease. J Thorac Cardiovasc Surg 2014;148(1):207–211.

    OpenUrl
14. 14.
    1. Kempny A,
    2. Dimopoulos K,
    3. Uebing A,
    4. Moceri P,
    5. Swan L,
    6. Gatzoulis MA,
    7. Diller GP

    . Reference values for exercise limitations among adults with congenital heart disease: relation to activities of daily life: single centre experience and review of published data. Eur Heart J 2012;33(11):1386–1396.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Rhodes J,
    2. Ubeda Tikkanen A,
    3. Jenkins KJ

    . Exercise testing and training in children with congenital heart disease. Circulation 2010;122(19):1957–1967.

    OpenUrlFREE Full Text
16. 16.↵
    1. Arena R,
    2. Sietsema KE

    . Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 2011;123(6):668–680.

    OpenUrlFREE Full Text
17. 17.↵
    1. Duppen N,
    2. Takken T,
    3. Hopman MT,
    4. ten Harkel AD,
    5. Dulfer K,
    6. Utens EM,
    7. Helbing WA

    . Systematic review of the effects of physical exercise training programmes in children and young adults with congenital heart disease. Int J Cardiol 2013;168(3):1779–1787.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Rosenblum O,
    2. Katz U,
    3. Reuveny R,
    4. Williams CA,
    5. Dubnov-Raz G

    . Exercise performance in children and young adults after complete and incomplete repair of congenital heart disease. Pediatr Cardiol 2015;36(8):1573–1581.

    OpenUrl
19. 19.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . ATS/ERS Task Force: standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Quanjer PH,
    2. Stanojevic S,
    3. Cole TJ,
    4. Baur X,
    5. Hall GL,
    6. Culver BH,
    7. et al

    . ERS Global Lung Function Initiative: multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40(6):1324–1343.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Godfrey S

    . Exercise testing in children: applications in health and disease, illustrated edition. New York: Saunders; 1974:68.
22. 22.↵
    1. Bongers BC,
    2. van Brussel M,
    3. Hulzebos EHJ,
    4. Takken T

    . Pediatric norms for cardiopulmonary exercise testing in relation to sex and age, 2nd edition. Hertogenbosch, Netherlands: Uitgeverij BOXpress; 2014.
23. 23.↵
    1. Stein R,
    2. Selvadurai H,
    3. Coates A,
    4. Wilkes DL,
    5. Schneiderman-Walker J,
    6. Corey M

    . Determination of maximal voluntary ventilation in children with cystic fibrosis. Pediatr Pulmonol 2003;35(6):467–471.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Wasserman K,
    2. Hansen J,
    3. Sue D,
    4. Stringer W,
    5. Whipp B

    , eds. Normal values. In: Principles of exercise testing and interpretation, 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2005:160–112.
25. 25.↵
    1. Opotowsky AR,
    2. Landzberg MJ,
    3. Earing MG,
    4. Wu FM,
    5. Triedman JK,
    6. Casey A,
    7. et al

    . Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. Am J Physiol Heart Circ Physiol 2014;307(1):H110–H117.

    OpenUrlAbstract/FREE Full Text
26. 26.
    1. Alderson PO,
    2. Boonvisut S,
    3. McKnight RC,
    4. Hartman AF Jr.

    . Pulmonary perfusion abnormalities and ventilation-perfusion imbalance in children after total repair of tetralogy of Fallot. Circulation 1976;53(2):332–337.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Yau KI,
    2. Fang LJ,
    3. Wu MH

    . Lung mechanics in infants with left-to-right shunt congenital heart disease. Pediatr Pulmonol 1996;21(1):42–47.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Greutmann M,
    2. Le TL,
    3. Tobler D,
    4. Biaggi P,
    5. Oechslin EN,
    6. Silversides CK,
    7. Granton JT

    . Generalised muscle weakness in young adults with congenital heart disease. Heart 2011;97(14):1164–1168.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Sciurba FC,
    2. Owens GR,
    3. Sanders MH,
    4. Griffith BP,
    5. Hardesty RL,
    6. Paradis IL,
    7. Costantino JP

    . Evidence of an altered pattern of breathing during exercise in recipients of heart-lung transplants. N Engl J Med 1988;319(18):1186–1192.

    OpenUrlPubMedWeb of Science
30. 30.↵
    1. Mattila IP,
    2. Sovijärvi A,
    3. Malmberg P,
    4. Heikkilä L,
    5. Sipponen J,
    6. Laitinen LA,
    7. Mattila SP

    . Altered regulation of breathing after bilateral lung transplantation. Eur J Cardiothorac Surg 1995;9(5):237–241.

    OpenUrlAbstract/FREE Full Text